Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of chronic hepatitis B: consensus guidelines.
Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, Yoshida E, Renner E, Wong P, Deschênes M. Sherman M, et al. Among authors: deschenes m. Can J Gastroenterol. 2007 Jun;21 Suppl C(Suppl C):5C-24C. Can J Gastroenterol. 2007. PMID: 17568823 Free PMC article.
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.
Watt KD, Burak K, Deschênes M, Lilly L, Marleau D, Marotta P, Mason A, Peltekian KM, Renner EL, Yoshida EM; Canadian Transplant Hepatology Outcomes Research Network. Watt KD, et al. Among authors: deschenes m. Can J Gastroenterol. 2006 Nov;20(11):725-34. doi: 10.1155/2006/238218. Can J Gastroenterol. 2006. PMID: 17111055 Free PMC article. Review.
Management of chronic hepatitis C: consensus guidelines.
Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, Yoshida E, Renner E, Wong P, Deschênes M. Sherman M, et al. Among authors: deschenes m. Can J Gastroenterol. 2007 Jun;21 Suppl C(Suppl C):25C-34C. Can J Gastroenterol. 2007. PMID: 17568824 Free PMC article.
Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?
Peltekian KM, Bain VG, Lee SS, Sherman M, Cooper CL, Yoshida EM, Marotta PJ, Krajden M, Balshaw R, Deschênes M. Peltekian KM, et al. Among authors: deschenes m. Ann Hepatol. 2011 Jul-Sep;10(3):260-9. Ann Hepatol. 2011. PMID: 21677327 Free article.
Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada.
Watt KD, Burak KW, Deschênes M, Lilly L, Marleau D, Marotta P, Mason A, Peltekian KM, Renner E, Yoshida EM; Canadian Transplant Hepatology Outcomes Research Network. Watt KD, et al. Among authors: deschenes m. Can J Gastroenterol. 2008 Feb;22(2):153-4. doi: 10.1155/2008/127684. Can J Gastroenterol. 2008. PMID: 18299733 Free PMC article.
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.
Yoshida EM, Sherman M, Bain VG, Cooper CL, Deschênes M, Marotta PJ, Lee SS, Krajden M, Witt-Sullivan H, Bailey RJ, Usaty C, Peltekian K; Pegasys Study Group. Yoshida EM, et al. Among authors: deschenes m. Can J Gastroenterol. 2009 Mar;23(3):180-4. doi: 10.1155/2009/470532. Can J Gastroenterol. 2009. PMID: 19319382 Free PMC article.
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.
Powis J, Peltekian KM, Lee SS, Sherman M, Bain VG, Cooper C, Krajden M, Deschenes M, Balshaw RF, Heathcote EJ, Yoshida EM; Canadian Pegasys Study Group. Powis J, et al. Among authors: deschenes m. J Viral Hepat. 2008 Jan;15(1):52-7. doi: 10.1111/j.1365-2893.2007.00889.x. J Viral Hepat. 2008. PMID: 18088245 Free PMC article. Clinical Trial.
382 results